HRMY Insider Trading Activity and SEC Form 4 Filings
Trump's trades in HRMY
From his financial disclosures
$30K+
2 purchases
$15K+
1 sale
Purchase
Mar 30, 2026
Reported 45d later
$15K - $50K
Sale
Feb 26, 2026
Reported 77d later
$15K - $50K
Purchase
Jan 26, 2026
Reported 108d later
$15K - $50K
Many orders in these accounts are placed by the account manager.
HRMY insider trading summary
Over the past 12 months, insiders at Harmony Biosciences Holdings, Inc. (HRMY) reported 9 sales worth $4.5M by 3 insiders and no open-market purchases on SEC Form 4. Net insider selling was $4.5M.
Latest HRMY insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 18, 2026 | Kumar Budur | Chief Medical Officer | Sell | $1.5M (35,852 @ $43.05) |
| Sep 17, 2026 | Kumar Budur | Chief Medical Officer | Sell | $34K (800 @ $43.00) |
| Sep 16, 2026 | Kumar Budur | Chief Medical Officer | Sell | $77K (1,800 @ $43.01) |
| Jan 26, 2026 | Sandip Kapadia | Chief Financial Officer | Sell | $139K (3,746 @ $37.15) |
| Jan 15, 2026 | Sandip Kapadia | Chief Financial Officer | Sell | $753K (20,961 @ $35.92) |
| Dec 12, 2025 | Jeffrey M. Dayno | President, CEO | Sell | $802K (20,000 @ $40.11) |
| Dec 12, 2025 | Jeffrey M. Dayno | President, CEO | Sell | $238K (5,933 @ $40.11) |
| Dec 5, 2025 | Sandip Kapadia | Chief Financial Officer | Sell | $791K (20,000 @ $39.54) |
| Nov 21, 2025 | Sandip Kapadia | Chief Financial Officer | Sell | $120K (3,427 @ $35.00) |
| Aug 15, 2025 | Sandip Kapadia | Chief Financial Officer | Sell | $787K (21,573 @ $36.50) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.